IL1B and atherosclerosis: The reduction in the expression of these pro-atherosclerotic markers could be explained by the reduction in pro-inflammatory cytokines such as TNFα, IL-6, IL-1α, IL-1β and TGF-α among others, which are stimuli that activated the expression of LOX-1, the principal receptor involved in atherosclerosis pathway[51].